Accelerating AI at Deloitte
Closing the gap between science fiction and reality
Artificial intelligence (AI) is one of those technologies that has captured the imagination of people worldwide
Its power to transform organisations, and even the economy, is becoming more and more evident. But it’s not just tech companies and start-ups that are affected by that transformation. There are exciting opportunities for traditional business too.
Findings from our latest State of Generative AI in the Enterprise study showed that two-thirds of business leaders (67%) reported their organisation is increasing its investment in Generative AI (GenAI).
Over the years Deloitte has built a strong reputation for helping organisations manage and implement new and disruptive technologies, as they progress from science fiction to business-as-usual.
How can businesses help make sure AI delivers a positive impact for all?
As a firm we have a responsibility to ensure the solutions we deliver, the connections we make and the way we work with AI can benefit society, as well as our people and clients.
It’s one of the reasons why, following the roll-out of our own internal GenAI platform ‘PairD’ to 75,000 of our people, we are also providing charities free access.
This includes Scope, a disability equality charity, who are now making use of the platform which currently helps our own people with day-to-day tasks, including drafting content, writing code and carrying out research safely and securely. Like all technology at Deloitte, we see PairD as a complementary tool that amplifies our people’s expertise and enables them to focus their time and energy on thinking creatively and making decisions based on the best insights available to them.
PairD launched in the Autumn of 2023, but as a firm we have been experimenting with GenAI for several years now. Deloitte’s AI Institute was created in 2019 to help our firm and clients prepare for the latest technological advances in AI, supporting them to transform with and apply AI through cutting-edge research and innovation.
Working on PairD has given Siman Li and her team valuable insights into scaling a GenAI platform from a proof of concept to an enterprise-wide solution.
“We have the expertise and skills we need to advise clients on a scalable GenAI solution as we’ve already released various updates [of PairD] within a year providing enhanced performance and extra features,” says Siman.
“As a team we’re always on top of the latest research and technologies.”
AI-powered content hub
Cutting down the time spent on monotonous tasks is a standout benefit of AI.
Deloitte’s work with one of the world’s biggest pharmaceutical companies for example, is helping to transform the way it delivers branded content across different channels around the globe.
Now, work that could take weeks takes just a few minutes!
As a global organisation, the pharmaceutical company needs to adapt content for its medical and sales representatives and local websites. This is to meet the important and specific requirements of different countries, which will often have their own medical jurisdictions, legal requirements and, of course, languages and local brand guidelines.
By creating an AI powered content production hub to make these adaptations, Deloitte is helping the company’s associates to access the information they need more quickly, to have important conversations with healthcare professionals in different parts of the world.
The objective, once the project is complete, is that the process for delivering the content and enabling its approval by the medical legal regulatory process can be reduced from a typical 90-120 days to just 12-15 days.
Illuminating supply chains at Johnson & Johnson
Within the Life Sciences industry, supply chain optimisation programmes need to carefully balance efficiency gains with the critical responsibilities of ensuring patient supply.
That’s where GenAI comes in – Deloitte has been working with Johnson & Johnson (J&J) to create a GenAI capability called ‘Agent Alpha’, which is helping the organisation to rapidly diagnose inventory improvement and wider end-to-end supply chain optimisation opportunities.
Agent Alpha helps J&J to rapidly exploit and interrogate the vast amounts of data across the end-to-end supply chain ecosystem, to unlock broader optimisation opportunities at a faster rate than ever before. By shedding light on sub-optimal performance, GenAI is being used by J&J to pinpoint interventions and equip end-users to drive continuous improvement right across the supply chains operating system.
Using GenAI to boost productivity within healthcare
We believe that through innovation and AI, we can help transform healthcare in the UK – it’s why we’ve set up the Clinify business with a clear goal: to use AI to boost the capacity of the NHS workforce and to help transform the delivery of healthcare.
We’re currently working with our NHS shared care record and technology alliance partners to create GenAI search and summarisation tools in health. These tools will connect all regional patient data in one place and make it easily accessible to health and social care professionals, in line with UK health data privacy requirements.
Healthcare teams currently encounter difficulties and time challenges extracting patient information from different clinical data sources. Using GenAI search and summarisation tools allow users to conduct healthcare-related and clinical searches across complex patient records from multiple sources. Early proof of concepts have shown it can deliver quick results with a summary of key sentences, and source references for clinical and healthcare teams – giving more time back to focus on patient care.
Adding value with AI
There's no doubt that there will be huge disruption in the way AI tools help us do our work but there will also be huge opportunities too.
We’re working with leading and emerging tech companies to build industry use cases and frameworks that advance and govern human-AI collaborations. From creating AI powered content hubs and supply chain optimisation tools, to extracting and summarising huge amounts of data with GenAI – adding value is at the heart of what we do.
As a firm we have a responsibility to ensure the solutions we deliver, the connections we make and the way we work with AI can benefit society, as well as our people and clients.
